|
Sections |
| Title | Starting Page | Number of Pages |
|---|
| 1 Table of Contents | 2 | 10 |
| 1.1 List of Tables | 7 | 3 |
| 1.2 List of Figures | 10 | 2 |
| 2 Introduction | 12 | 1 |
| 2.1 What Is This Report About? | 12 | 1 |
| 3 Definitions of Markets Covered in This Report | 13 | 3 |
| 3.1 Neurology Devices | 13 | 1 |
| 3.2 CSF Management | 13 | 1 |
| 3.2.1 Hydrocephalus Shunts | 13 | 1 |
| 3.2.2 ICP Monitoring Devices | 13 | 1 |
| 3.3 Interventional Neurology | 13 | 1 |
| 3.3.1 Aneurysm Clips | 13 | 1 |
| 3.3.2 Embolic Systems | 13 | 1 |
| 3.3.3 Navigational Systems | 13 | 1 |
| 3.4 Neurostimulation Devices | 13 | 1 |
| 3.4.1 Deep Brain Stimulators | 14 | 1 |
| 3.4.2 Spinal Cord Stimulators | 14 | 1 |
| 3.4.3 Vagus Nerve Stimulators | 14 | 1 |
| 3.5 Neurosurgical Products | 14 | 1 |
| 3.5.1 Neuroendoscopes | 14 | 1 |
| 3.6 Radiosurgery | 14 | 1 |
| 3.6.1 CyberKnife Radiosurgery | 14 | 1 |
| 3.6.2 GammaKnife Radiosurgery | 14 | 2 |
| 4 Healthcare Sector Review | 16 | 8 |
| 4.1 Healthcare Expenditure | 16 | 3 |
| 4.2 Healthcare Infrastructure | 19 | 1 |
| 4.2.1 Healthcare Personnel Data | 20 | 1 |
| 4.2.2 Healthcare Facilities Data | 21 | 1 |
| 4.3 Healthcare Policy | 22 | 2 |
| 5 Regulation System | 24 | 14 |
| 5.1 Medical Equipment Approval Process | 24 | 1 |
| 5.1.1 Classification | 25 | 8 |
| 5.1.2 Conformity Assessment Process | 33 | 1 |
| 5.1.2.1 Class I devices | 33 | 1 |
| 5.1.2.2 Class IIa devices | 34 | 1 |
| 5.1.2.3 Class IIb devices | 35 | 1 |
| 5.1.2.4 Class III devices | 36 | 1 |
| 5.2 Notification Fee | 37 | 1 |
| 6 Pricing and Reimbursement | 38 | 1 |
| 6.1 Reimbursement Policies | 38 | 1 |
| 7 Distribution Structure | 39 | 1 |
| 8 Neurology Devices In Belgium | 40 | 9 |
| 8.1 Neurology Devices, Belgium, Overall Revenue ($ mn), 2000-2015 | 40 | 6 |
| 8.2 Neurology Devices, Belgium, Category Volume (Units), 2000-2015 | 46 | 2 |
| 8.3 Neurology Devices, Belgium, Company Share (2007-2008) | 48 | 1 |
| 9 CSF Management In Belgium | 49 | 7 |
| 9.1 CSF Management Overall Revenue (2000-2015) | 49 | 2 |
| 9.2 CSF Management Overall Volume (2000-2015) | 51 | 2 |
| 9.3 CSF Management Average Price (2000-2015) | 53 | 1 |
| 9.4 CSF Management Distribution Share (2007-2008) | 54 | 1 |
| 9.5 CSF Management, Belgium, Company Share (2007-2008) | 55 | 1 |
| 10 Interventional Neurology In Belgium | 56 | 15 |
| 10.1 Interventional Neurology Overall Revenue (2000-2015) | 56 | 2 |
| 10.1.1 Embolic Systems Revenue (2000-2015) | 58 | 2 |
| 10.1.2 Navigational Systems Revenue (2000-2015) | 60 | 2 |
| 10.2 Interventional Neurology Overall Volume (2000-2015) | 62 | 2 |
| 10.2.1 Embolic Systems Revenue (2000-2015) | 64 | 2 |
| 10.2.2 Navigational Systems Revenue (2000-2015) | 66 | 2 |
| 10.3 Interventional Neurology Average Price (2000-2015) | 68 | 1 |
| 10.4 Interventional Neurology Distribution Share (2007-2008) | 69 | 1 |
| 10.5 Interventional Neurology, Belgium, Company Share (2007-2008) | 70 | 1 |
| 11 Neurostimulation Devices In Belgium | 71 | 7 |
| 11.1 Neurostimulation Devices Overall Revenue (2000-2015) | 71 | 2 |
| 11.2 Neurostimulation Devices Overall Volume (2000-2015) | 73 | 2 |
| 11.3 Neurostimulation Devices Average Price (2000-2015) | 75 | 1 |
| 11.4 Neurostimulation Devices Distribution Share (2007-2008) | 76 | 1 |
| 11.5 Neurostimulation Devices, Belgium, Company Share (2007-2008) | 77 | 1 |
| 12 Neurosurgical Products In Belgium | 78 | 7 |
| 12.1 Neurosurgical Products Overall Revenue (2000-2015) | 78 | 2 |
| 12.2 Neurosurgical Products Overall Volume (2000-2015) | 80 | 2 |
| 12.3 Neurosurgical Products Average Price (2000-2015) | 82 | 1 |
| 12.4 Neurosurgical Products Distribution Share (2007-2008) | 83 | 1 |
| 12.5 Neurosurgical Products, Belgium, Company Share (2007-2008) | 84 | 1 |
| 13 Radiosurgery In Belgium | 85 | 7 |
| 13.1 Radiosurgery Overall Revenue (2000-2015) | 85 | 2 |
| 13.2 Radiosurgery Overall Volume (2000-2015) | 87 | 2 |
| 13.3 Radiosurgery Average Price (2000-2015) | 89 | 1 |
| 13.4 Radiosurgery Distribution Share (2007-2008) | 90 | 1 |
| 13.5 Radiosurgery, Belgium, Company Share (2007-2008) | 91 | 1 |
| 14 Overview of Key Companies in Belgium Neurology Devices Market | 92 | 29 |
| 14.1 Medtronic, Inc. | 92 | 1 |
| 14.1.1 Company Overview | 92 | 1 |
| 14.1.2 Medtronic, Inc. Pipeline Products | 93 | 1 |
| 14.1.2.1 Medtronic, Inc. Pipeline Products By Equipment Type | 93 | 2 |
| 14.1.2.2 Medtronic, Inc. Pipeline Products By Development Stage | 95 | 2 |
| 14.1.2.3 Medtronic, Inc. Pipeline Products By Therapy Area | 97 | 2 |
| 14.1.2.4 Medtronic, Inc. Pipeline Products By Clinical Trials | 99 | 1 |
| 14.1.2.5 Medtronic, Inc. Pipeline Products By News Summary | 100 | 2 |
| 14.2 Boston Scientific Corporation | 102 | 1 |
| 14.2.1 Company Overview | 102 | 1 |
| 14.2.2 Boston Scientific Corporation Pipeline Products | 103 | 1 |
| 14.2.2.1 Boston Scientific Corporation Pipeline Products By Equipment Type | 103 | 1 |
| 14.2.2.2 Boston Scientific Corporation Pipeline Products By Development Stage | 104 | 1 |
| 14.2.2.3 Boston Scientific Corporation Pipeline Products By Therapy Area | 105 | 1 |
| 14.2.2.4 Boston Scientific Corporation Pipeline Products By Clinical Trials | 106 | 1 |
| 14.2.2.5 Boston Scientific Corporation Pipeline Products By News Summary | 107 | 1 |
| 14.3 Cordis Corporation | 108 | 1 |
| 14.3.1 Company Overview | 108 | 1 |
| 14.4 Elekta AB | 108 | 1 |
| 14.4.1 Company Overview | 108 | 1 |
| 14.5 Cyberonics, Inc. | 109 | 1 |
| 14.5.1 Company Overview | 109 | 1 |
| 14.5.2 Cyberonics, Inc. Pipeline Products | 109 | 1 |
| 14.5.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type | 109 | 1 |
| 14.5.2.2 Cyberonics, Inc. Pipeline Products By Development Stage | 109 | 1 |
| 14.5.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area | 109 | 1 |
| 14.6 ev3 Inc. | 110 | 1 |
| 14.6.1 Company Overview | 110 | 1 |
| 14.7 B. Braun Melsungen AG | 110 | 1 |
| 14.7.1 Company Overview | 110 | 1 |
| 14.8 Codman & Shurtleff, Inc | 111 | 1 |
| 14.8.1 Company Overview | 111 | 1 |
| 14.9 St. Jude Medical, Inc. | 112 | 1 |
| 14.9.1 Company Overview | 112 | 1 |
| 14.9.2 St. Jude Medical Inc. Pipeline Products | 112 | 1 |
| 14.9.2.1 St. Jude Medical Inc. Pipeline Products By Equipment Type | 112 | 2 |
| 14.9.2.2 St. Jude Medical Inc. Pipeline Products By Development Stage | 114 | 1 |
| 14.9.2.3 St. Jude Medical Inc. Pipeline Products By Therapy Area | 115 | 1 |
| 14.9.2.4 St. Jude Medical Inc. Pipeline Products By Clinical Trials | 116 | 1 |
| 14.9.2.5 St. Jude Medical Inc. Pipeline Products By News Summary | 117 | 1 |
| 14.10 Integra LifeSciences Holdings Corporation | 118 | 1 |
| 14.10.1 Company Overview | 118 | 1 |
| 14.11 KARL STORZ GmbH & Co. KG | 118 | 1 |
| 14.11.1 Company Overview | 118 | 1 |
| 14.12 OLYMPUS CORPORATION | 119 | 1 |
| 14.12.1 Company Overview | 119 | 1 |
| 14.13 VYGON Neuro | 119 | 1 |
| 14.13.1 Company Overview | 119 | 1 |
| 14.14 Advanced Neuromodulation Systems, Inc. | 120 | 1 |
| 14.14.1 Company Overview | 120 | 1 |
| 15 Appendix | 121 | 5 |
| 15.1 Global Markets Direct Research Methodology | 121 | 1 |
| 15.2 Secondary Research | 122 | 1 |
| 15.3 Primary Research | 122 | 1 |
| 15.4 Models | 123 | 1 |
| 15.5 Forecasts | 123 | 1 |
| 15.6 Expert Panel Validation | 123 | 1 |
| 15.7 Currency Conversion | 124 | 1 |
| 15.8 Contact Us | 125 | 1 |
| 15.9 Disclaimer | 125 | 1 |